Furthermore, we compared the ROC curves of IgM-free AIM calculated from specificity and sensitivity with those of the conventional HCC biomarkers, AFP and DCP, for each liver disease related to NASH, HCV, HBV, and for all the patients. The gene discussed is CD40LG; the disease is hepatocellular carcinoma.